GlassScriptPhysician profile
Brandon R Hill
NPI 1376754879
$53,452.93
in general payments reported to CMS, 2019-2025
20 companies · $19K in 2025
The $19K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,577 · 2020: $665 · 2021: $6,491 · 2022: $1,026 · 2023: $8,203 · 2024: $17K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $8,876 · Grant: $5,500 · Education: $4,000 · Travel and Lodging: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,320.00 |
| Food and Beverage | $8,875.95 |
| Grant | $5,500.00 |
| Education | $4,000.00 |
| Travel and Lodging | $997.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $40,537.66 | 2021-2025 | Corevalve Evolut R, Micra, Abre |
| Intuitive Surgical, INC. | $4,150.00 | 2025 | |
| Abbott Laboratories | $2,781.13 | 2019-2025 | Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $2,238.85 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $1,634.03 | 2019-2020 | |
| Abiomed | $469.01 | 2021-2025 | Impella |
| W. L. Gore & Associates, INC. | $427.58 | 2021-2024 | Gore Tag Thoracic Branch Endoprosthesis, C3 Delivery System, Gore Excluder Iliac Branch Endoprosthesis |
| Atricure, INC. | $245.09 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Penumbra, INC. | $220.01 | 2022-2023 | Indigo System |
| Intact Vascular, INC. | $175.00 | 2019 | |
| Boston Scientific Corporation | $163.44 | 2024-2025 | Watchman Access System |
| Stryker Corporation | $144.72 | 2025 | Limflow System |
| Philips North America LLC | $96.13 | 2022-2023 | |
| Integra Lifesciences Corporation | $31.26 | 2024 | Medihoney, Biodrestore, Biofix |
| Smith+Nephew, INC. | $29.21 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $25.53 | 2024 | |
| Kls-Martin L.P. | $25.13 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $20.48 | 2023 | Xarelto |
| Ethicon US, LLC | $19.37 | 2023 | Stratafix, Echelon Endopath, Echelon Flex |
| Bolton Medical INC | $19.30 | 2025 | Thoraflex Hybrid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.